Results 311 to 320 of about 5,673,125 (350)

Adagrasib in the treatment of colorectal cancer. [PDF]

Future Oncol
Haddad SF, Bouferraa Y, Nair KG.
europepmc   +1 more source

Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation

Advanced Science, EarlyView.
In ulcerative colitis, the loss of Odoribacter splanchnicus disrupts a microbiota‐metabolite‐neutrophil axis. Restoring this bacterium boosts lithocholic acid, which suppress neutrophil extracellular trap formation and eases colonic inflammation.
Jing Xu, Jianhong Li, Xue Guo, Chen Huang, Yao Peng, Haoming Xu, Yingfei Li, Jingkui Xu, Jinxia Hu, Yitong Liao, Yuqiang Nie, Youlian Zhou   +11 more
wiley   +1 more source

Multiple polygenic score approach in colorectal cancer risk prediction. [PDF]

Sci Rep
Jiang SJ, Thomas M, Rosenthal EA, Phipps AI, Sakoda LC, van Duijnhoven FJB, Pellatt AJ, Avery CL, Berndt SI, Bishop DT, Castellví-Bel S, Chan AT, Grant RC, Gignoux C, Gsur A, Gunter MJ, Haiman CA, Hoffmeister M, Jarvik GP, Jenkins MA, Keku TO, Küry S, Lee JK, Marchand LL, Moreno V, Newcomb PA, Newton CC, Ogino S, Palmer JR, Pearlman R, Qu C, Schoen RE, Um CY, Van Guelpen B, Visvanathan K, Vymetalkova V, White E, Woods MO, Platz EA, Brenner H, Corley DA, Vogelaar IL, Hsu L, Peters U.   +43 more
europepmc   +1 more source

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation

Advanced Science, EarlyView.
Preparation of a biopolymer‐based immune implant (BI) for the sustained release of R848 and oxaliplatin (OXA), enabling immune activation and preventing recurrence after radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC). Abstract Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high ...
Yuezhan Shan, Hongyu Chu, Sheyu Ye, Guofeng Ji, Jiayi Zhao, Xinghui Si, Yumin Zhong, Youmao Tao, Jingwei Shi, Xuedong Fang   +9 more
wiley   +1 more source

Advances in the multifunctionality of cell membrane-encapsulated nanoparticles in the treatment of colorectal cancer. [PDF]

Front Immunol
Qiu Z, Liu W, Xu S.
europepmc   +1 more source

Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment

Jun Wang, Shenghe Deng, Denglong Cheng, Junnan Gu, Le Qin, Fuwei Mao, Yifan Xue, Zhenxin Jiang, Mian Chen, Falong Zou, Ning Huang, Yinghao Cao, Kailin Cai   +12 more
openalex   +1 more source

Comprehensive evaluation and progress of colorectal cancer screening methods. [PDF]

Gut Pathog
Jiaqun H, Jing Z, Yunfeng Y, Yiren H, Yinhang W, Shuwen H, Wei W.   +6 more
europepmc   +1 more source

Correction: Fibrinogen and colorectal cancer: A study of the Chinese population. [PDF]

PLoS One
Wang J, Li J, Huo J, Zhao Y, Liu K, Wang H, Cao X.   +6 more
europepmc   +1 more source

A hybrid framework for enhanced segmentation and classification of colorectal cancer histopathology. [PDF]

Front Artif Intell
M D A, B V.
europepmc   +1 more source

Advances in the Use of Immune Checkpoint Inhibitors for Colorectal Cancer Treatment. [PDF]

Onco Targets Ther
Li J, Fu T, Wen Z, Liang J, Qiu Y, Li K, Yang J, Tong Y, Cai H.   +8 more
europepmc   +1 more source